Novel CD22 CAR-T therapy for paediatric leukaemia
16 Jun 2018
Novel CD22 CAR-T therapy for paediatric leukaemia
EHA 2018: Research, collaboration and working towards cures
Educational focus on immunotherapy at EHA
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma
EHA Topics in focus : Immunotherapy
Novel ADC for relapsed/refractory lymphoma
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
EHA 2018: Results of the OPTIMISMM trial
Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Updates from Myeloma XI trial
Ribosomal lesions promote oncogenic mutagenesis
Interim results of RELEVANCE trial in follicular lymphoma